4.6 Article

Plasma apolipoprotein A1 associates with age at onset and motor severity in early Parkinson's disease patients

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Clinical Neurology

Plasma Apolipoprotein A1 as a Biomarker for Parkinson Disease

Judy K. Qiang et al.

ANNALS OF NEUROLOGY (2013)

Article Medicine, General & Internal

Low uric acid levels in patients with Parkinson's disease: evidence from meta-analysis

Liang Shen et al.

BMJ OPEN (2013)

Article Clinical Neurology

Cerebrospinal Fluid Biomarkers for Parkinson Disease Diagnosis and Progression

Min Shi et al.

ANNALS OF NEUROLOGY (2011)

Review Clinical Neurology

Milestones in Parkinson's Disease Therapeutics

Olivier Rascol et al.

MOVEMENT DISORDERS (2011)

Review Neurosciences

The Parkinson Progression Marker Initiative (PPMI)

Kenneth Marek et al.

PROGRESS IN NEUROBIOLOGY (2011)

Article Cell Biology

Biomarkers for Parkinson's Disease

Todd B. Sherer

SCIENCE TRANSLATIONAL MEDICINE (2011)

Article Clinical Neurology

Serum urate as a predictor of clinical and radiographic progression in Parkinson disease

Michael A. Schwarzschild et al.

ARCHIVES OF NEUROLOGY (2008)

Article Public, Environmental & Occupational Health

Plasma urate and risk of Parkinson's disease

M. G. Weisskopf et al.

AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)

Article Biochemistry & Molecular Biology

Decreased α-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson's disease

Takahiko Tokuda et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)

Article Clinical Neurology

Serum uric acid levels and the risk of Parkinson disease

LML de Lau et al.

ANNALS OF NEUROLOGY (2005)

Review Ophthalmology

Macular microcirculation characteristics in Parkinson's disease evaluated by OCT-Angiography: a literature review

Evita Evangelia Christou et al.

Summary: The retina may serve as a predictive factor for neurodegenerative disorders, with recent use of Optical Coherence Tomography Angiography (OCT-A) in studying macular microcirculation changes in Parkinson's disease (PD). While preliminary evidence suggests OCT-A could be a useful biomarker for cerebral vasculature in PD, further research is needed to confirm its predictive value in clinical practice.

SEMINARS IN OPHTHALMOLOGY